Skip to main content

Advertisement

Log in

Comparison of resection margin status after single or double radiopaque marker insertion for tumor localization in breast cancer patients receiving neoadjuvant chemotherapy

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose

Insertion of radiopaque markers is helpful for tumor localization in patients receiving neoadjuvant chemotherapy (NAC) followed by breast-conserving surgery (BCS). The aim of this retrospective study was to investigate the pathologic margin status in patients with single or double marker insertion.

Methods

We reviewed the records of 130 patients with marker insertion prior to NAC followed by BCS from January 2016 to September 2019. Under ultrasonography guidance, single or double markers were inserted to localize a tumor in the breast. The incidence of additional resection after frozen biopsy and re-excision after permanent pathologic diagnosis was analyzed.

Results

In a total of 130 patients, 104 had a single marker in the center of the tumor and 26 had double markers at the periphery of the tumor before NAC. Among 69 patients with residual invasive tumors after NAC, there was no difference in the additional resection rate after frozen biopsy (single vs. double markers; 14.3% vs. 38.5%, P = .059) or the re-excision rate after final pathologic diagnosis (0% vs. 7.7%, P = .188). After propensity score matching for tumor size and subtypes, the two groups showed no differences in the additional resection rate after frozen biopsy (7.7% vs. 19.2%, P = .139) or the re-excision rate (0% vs. 3.8%, P = .308). After a median follow-up of 19 months (range 8–48 months), local recurrence-free survival did not differ between the two groups (log-rank P = .456).

Conclusions

Number of inserted markers for tumor localization did not affect the pathologic margin status after BCS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Kaufmann M, von Minckwitz G, Bear HD, Buzdar A, McGale P, Bonnefoi H et al (2007) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol 18(12):1927–1934

    Article  CAS  Google Scholar 

  2. Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M et al (2012) Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol 19(5):1508–1516

    Article  Google Scholar 

  3. Youn I, Choi SH, Kook SH, Choi YJ, Park CH, Park YL et al (2015) Ultrasonography-guided surgical clip placement for tumor localization in patients undergoing neoadjuvant chemotherapy for breast cancer. J Breast Cancer 18(1):44–49

    Article  Google Scholar 

  4. Schulz-Wendtland R, Dankerl P, Bani MR, Fasching PA, Heusinger K, Lux MP et al (2017) Evaluation of a marker clip system in sonographically guided core needle biopsy for breast cancer localization before and after neoadjuvant chemotherapy. Geburtshilfe Frauenheilkd 77(2):169–175

    Article  CAS  Google Scholar 

  5. Koo JH, Kim EK, Moon HJ, Yoon JH, Park VY, Kim MJ (2019) Comparison of breast tissue markers for tumor localization in breast cancer patients undergoing neoadjuvant chemotherapy. Ultrasonography 38(4):336–344

    Article  Google Scholar 

  6. Pinkney DM, Mychajlowycz M, Shah BA (2016) A prospective comparative study to evaluate the displacement of four commercially available breast biopsy markers. Br J Radiol 89(1065):20160149

    Article  Google Scholar 

  7. Oh JL, Nguyen G, Whitman GJ, Hunt KK, Yu TK, Woodward WA et al (2007) Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110(11):2420–2427

    Article  Google Scholar 

  8. Moran MS, Schnitt SJ, Giuliano AE et al (2014) Society of surgical oncology-American Society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol 21(3):704–716

    Article  Google Scholar 

  9. Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V et al (2007) Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 25(28):4414–4422

    Article  Google Scholar 

  10. Bossuyt V, Provenzano E, Symmans WF, Boughey JC, Coles C, Curigliano G et al (2015) Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Ann Oncol 26(7):1280–1291

    Article  CAS  Google Scholar 

  11. Sahoo S, Lester SC (2012) Pathology considerations in patients treated with neoadjuvant chemotherapy. Surg Pathol Clin 5(3):749–774

    Article  Google Scholar 

  12. Pusztai L, Foldi J, Dhawan A, DiGiovanna MP, Mamounas EP (2019) Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers. Lancet Oncol 20(7):e390–e396

    Article  Google Scholar 

  13. Cain H, Macpherson IR, Beresford M, Pinder SE, Pong J, Dixon JM (2017) Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice. Clin Oncol (R Coll Radiol) 29(10):642–652

    Article  CAS  Google Scholar 

  14. Aggarwal V, Agarwal G, Lal P, Krishnani N, Mishra A, Verma AK et al (2008) Feasibility study of safe breast conservation in large and locally advanced cancers with use of radiopaque markers to mark pre-neoadjuvant chemotherapy tumor margins. World J Surg 32(12):2562–2569

    Article  Google Scholar 

  15. Espinosa-Bravo M, Sao Aviles A, Esgueva A, Cordoba O, Rodriguez J, Cortadellas T et al (2011) Breast conservative surgery after neoadjuvant chemotherapy in breast cancer patients: comparison of two tumor localization methods. Eur J Surg Oncol 37(12):1038–1043

    Article  CAS  Google Scholar 

  16. Thomassin-Naggara I, Lalonde L, David J, Darai E, Uzan S, Trop I (2012) A plea for the biopsy marker: how, why and why not clipping after breast biopsy? Breast Cancer Res Treat 132(3):881–893

    Article  Google Scholar 

  17. Ruland AM, Hagemann F, Reinisch M, Holtschmidt J, Kummel A, Dittmer-Grabowski C et al (2018) Using a New marker clip system in breast cancer: Tumark vision® clip—feasibility testing in everyday clinical practice. Breast Care (Basel) 13(2):116–120

    Article  Google Scholar 

  18. Masroor I, Zeeshan S, Afzal S, Sufian SN, Ali M, Khan S et al (2015) Outcome and cost effectiveness of ultrasonographically guided surgical clip placement for tumor localization in patients undergoing neo-adjuvant chemotherapy for breast cancer. Asian Pac J Cancer Prev 16(18):8339–8343

    Article  Google Scholar 

  19. Volders JH, Haloua MH, Krekel NM, Negenborn VL, Barbe E, Sietses C et al (2016) Neoadjuvant chemotherapy in breast-conserving surgery—consequences on margin status and excision volumes: a nationwide pathology study. Eur J Surg Oncol 42(7):986–993

    Article  CAS  Google Scholar 

  20. Volders JH, Negenborn VL, Spronk PE, Krekel NMA, Schoonmade LJ, Meijer S et al (2018) Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes. Breast Cancer Res Treat 168(1):1–12

    Article  Google Scholar 

  21. Sahoo S, Lester SC (2009) Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting. Arch Pathol Lab Med 133(4):633–642

    PubMed  Google Scholar 

  22. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED et al (2004) Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22(12):2303–2312

    Article  Google Scholar 

  23. Wang S, Zhang Y, Yang X, Fan L, Qi X, Chen Q et al (2013) Shrink pattern of breast cancer after neoadjuvant chemotherapy and its correlation with clinical pathological factors. World J Surg Oncol 11(1):166

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the Department of Biostatistics, Yonsei University College of Medicine, for assistance in statistical analysis

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joon Jeong.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 1177 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cha, C., Lee, J., Kim, D. et al. Comparison of resection margin status after single or double radiopaque marker insertion for tumor localization in breast cancer patients receiving neoadjuvant chemotherapy. Breast Cancer Res Treat 184, 797–803 (2020). https://doi.org/10.1007/s10549-020-05907-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-020-05907-9

Keywords

Navigation